Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 6, 2000, Pages 1402-1409

  Cheng, Hao ^a   Tumpey, Terrence M ^a   Staats, Herman F ^b   Van Rooijen, Nico ^c   Oakes, John E ^a   Lausch, Robert N ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; KERATITIS; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

ACID PHOSPHATASE; ANIMALS; ANTIBODIES, VIRAL; CLODRONIC ACID; CORNEA; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRUS 1, HUMAN; HYPERSENSITIVITY, DELAYED; IMMUNOENZYME TECHNIQUES; KERATITIS, HERPETIC; LANGERHANS CELLS; MACROPHAGES; MICE; MICE, INBRED BALB C; VIRUS REPLICATION;

EID: 0034058179     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Tumpey TM, Chen S-H, Oakes JE, Lausch RN. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol. 1996;70:898-904.
2. Su Y-H, Oakes JE, Lausch RN. Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity of α/β interferon. J Virol. 1990;64:2187-2192.
3. Hendricks RL, Weber PC, Taylor JL, Koumbis A, Tumpey TM, Glorioso JC. Endogenously produced interferon a protects mice from herpes simplex virus type 1 corneal disease. J Gen Virol. 1991;72:1601-1610.
4. Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med. 1999;189:663-672.
5. Rand KH, Rasmussen LE, Pollard R.B, Arvin A, Merigan TC. Cellular immunity and herpesvirus infections in cardiac-transplant patients. N Engl J Med. 1977;296:1372-1377.
6. + T cells participate in recovery from ocular herpes simplex virus type 1 infection. Invest Ophthalmol Vis Sci. 1984;25:188-194.
7. Lausch RN, Monterio C, Kleinschrodt WR, Oakes JE. Superiority of antibody versus delayed hypersensitivity in clearance of HSV-2 from eye. Invest Ophthalmol Vis Sci. 1987;28:565-570.
8. Lausch RN, Oakes JE, Metcalf JF, Scimeca JM, Smith LA, Robertson SM. Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice. Curr Eye Res. 1989; 8:499-506.
9. + cells. J Virol. 1991;65:6008-6014.
10. Johnson RT. The pathogenesis of herpes virus encephalitis, II: a cellular basis for the development of resistance with age. J Exp Med. 1964;120:359-374.
11. Zisman B, Hirsch MS, Allison AC. Selective effects of anti-macrophage serum, silica, and anti-lymphocyte serum in pathogenesis of herpes virus infection of young adult mice. J Immunol. 1970;104: 1155-1159.
12. Wu L, Morahan PS. Macrophages and other non-specific defenses: role of modulating resistance against herpes simplex virus. Curr Top Microbiol Immunol. 1992;179:89-110.
13. Rossol-Voth R, Rossol S, Schutt KH, Corridori S, deCian W, Falke D. In vivo protective effect of tumor necrosis factor a against experimental infection with herpes simplex virus type 1. J Gen Virol. 1991;72:143-147.
14. Chen S-H, Oakes JE, Lausch RN. Synergistic anti-HSV effect of tumor necrosis factor alpha and interferon gamma in human corneal fibroblasts is associated with interferon beta induction. Anti-viral Res. 1993;22:15-29.
15. Chen S-H, Oakes JE. Lausch RN. Synergistic anti-herpes effect of TNF-α and IFN-γ in human corneal epithelial cells compared with that in corneal fibroblasts. Antiviral Res. 1994;25:201-213.
16. Widmer U, Manogue KR, Cerami A, Sherry B. Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine super-family of proinflammatory cytokines. J Immunol. 1993;150:4996-5012.
17. Ziegler K, Unanue ER. Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J Immunol. 1981;127:1869-1875.
18. Ziegler HK, Unanue ER. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci USA. 1982;79:175-178.
19. Unanue ER, Allen PM. The basis for the immunoregulatory role of macrophages and other accessory cells. Science. 1987;236:551-557.
20. Claassen I, van Rooijen N, Claassen E. A new method for removal of mononuclear phagocytes from heterogeneous cell populations in vitro, using the liposome-mediated macrophage 'suicide' technique. J Immunol Methods. 1990;134:153-161.
21. Delemarre FG, Kors N, Kraal G, van Rooijen N. Repopulation of macrophages in popliteal lymph nodes of mice after liposome-mediated depletion. J Leukoc Biol. 1990,47:251-257.
22. Qian Q, Jutila MA, van Rooijen N, Cutler JE. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J Immunol. 1994;152: 5000-5008.
23. van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174:83-93.
24. Naito M, Nagai H, Kawano S, et al. Liposome-encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro. J Leukoc Biol. 1996;60:337-344.
25. van Rooijen N, Sanders A, van den Berg TK Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J Immunol Methods. 1996;193:93-99.
26. Lausch RN, Kleinschrodt WR, Monteiro C, Kayes SG, Oakes JE Resolution of HSV corneal infection in the absence of delayed-type hypersensitivity. Invest Ophthalmol Vis Sci. 1985;26:1509-1515.
27. Staats HF, Nichols WG, Palker TJ. Mucosal immunity to HSV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J Immunol. 1996;157:462-472.
28. Staats HF, Montgomery SP, Palker TJ. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses. AIDS Res Hum Retroviruses. 1997;13:945-952.
29. van Klink F, Taylor WM, Alizadeh H, Jager MJ, van Rooijen N, Niederkorn JY. The role of macrophages in acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 1996;37:1271-1281.
30. Kraal G, Breel M, Janse M, Bruin G. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J Exp Med. 1986;163:981-997.
31. van Rooijen N, van Nieuwmegcn R. Elimination of phagocytic cells in the spleen after intravenous injection of liposome-encapsulated dichloromethylene diphosphonate: an enzytne-histochemical study. Cell Tissue Res. 1984;238:355-358.
32. van Rooijen N, Kors N, van de Ende M, Dijkstra CD. Depletion and repopulation of macrophages in spleen and liver of rat after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res. 1990;260:215-222.
33. Tilney NL. Patterns of lymphatic drainage in the adult laboratory rat. J Anat. 1971;109:369-383.
34. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate: functional and morphological studies. J Exp Med. 1987;166:1654-1667.
35. Larsen CP, Steinman RM, Witmer-Pack M, Hankins DF, Morris PJ, Austyn JM. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med. 1990;172:1483-1493.
36. Cumberbatch M, Kimber I. Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology. 1995;84:31-35.
37. Austyn JM. Antigen uptake and presentation by dendritic leukocytes. Semin Immunol. 1992;4:227-236.
38. Chesnut RW, Colon SM, Grey HM. Requirements for the processing of antigens by antigen-presenting B cells, 1: Functional comparison of B cell tumors and macrophages. J Immunol. 1982;129: 2382-2388.
39. Grey HM, Colon SM, Chesnut RW. Requirements for the processing of antigen by antigen-presenting B cells, II: Biochemical comparison of the fate of antigen in B cell tumors and macrophages. J Immunol. 1982;129:2389-2395.
40. Karupiah G, Buller RM, van Rooijen N, Duarte CJ, Chen J. Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection. J Virol. 1996;70: 8301-8309.
41. Bachmann MF, Zinkernagel RM, Oxenius A. Immune responses in the absence of costimulation: viruses know the trick. J Immunol. 1998;161:5791-5794.
42. Wijburg OL, Heemskerk MH, Boog CJ, van Rooijen N. Role of spleen macrophages in innate and acquired immune responses against mouse hepatitis virus strain A59. Immunology. 1997;92: 252-258.
43. Lodmell DL, Niwa A, Hayashi K, Notkins AL. Prevention of cell-to-cell spread of herpes simplex virus by leukocytes. J Exp Med. 1973;137:706-720.
44. Zisman B, Wheelock EF, Allison AC. Role of macrophages and antibody in resistance of mice against yellow fever virus. J Immunol. 1971;107:236-243.
45. Ben-Nathan B, Huitinga I, Lustig S, van Rooijen N, Kobiler D. West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice. Arch Virol. 1996;141:459-469.
46. Mestan J, Digel W, Mittnacht S, et al. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature. 1986;323:816-819.
47. Ito M, O'Malley JA. Antiviral effects of recombinant human tumor necrosis factor. Lymphokine Res. 1987;6:309-318.
48. Hendricks RL, Junowicz M, Tumpey TM. Critical role of corneal Langerhans cells in the CD4-but not CD8-mediated immunopathology in herpes simplex vims-1-infected mouse corneas. J Immunol. 1992;148:2522-2529.
49. Chen H, Hendricks RL. B7 costimulatory requirements of T cells at an inflammatory site. J Immunol. 1998;160:5045-5052.
50. Nair S, Buiting AM, Rouse RJ, van Rooijen N, Huang L, Rouse BT. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int Immunol. 1995;7:679-688.
51. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994; 179:1109-1118.